Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome	Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute biphenotypic leukemia, acute disease, acute myeloid leukemia, bone marrow disorder, disease, graft versus host disease, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, mixed phenotype acute leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm, precancerous condition, syndromic disease	Recruiting	Phase 2	2026-07-07		NCT07216443

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Orca Biosystems, Inc.	8

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
John Theurer Cancer Center at Hackensack University Medical Center	Hackensack	United States	37
Moffitt Cancer Center	Tampa	United States	523
Oregon Health and Science University	Portland	United States	382
UCLA Department of Medicine	Los Angeles	United States	3
Vanderbilt University, Ingram Cancer Center	Nashville	United States	1
Weill Cornell Medicine - New York Presbyterian Hospital	New York	United States	6